A new clinical trial will explore three interventions in improving one of the most disabling symptoms for people with multiple sclerosis: fatigue.
The Patient-Centered Outcomes Research Institute has approved a $3,476,448 funding award over four years to Michigan Medicine’s Tiffany Braley, M.D., M.S. and Anna Kratz, Ph.D., both IHPI members.
“This clinical trial (link is external) will use a patient-centered approach that takes into account the many facets of MS, in order to directly impact clinical practice and payer coverage of two of the most widely accepted treatments for MS fatigue,” says Braley, assistant professor of neurology.
The researchers say a lack of evidence to help patients and other stakeholders choose from the available care options makes this topic important to explore.
“The interdisciplinary nature of this study team is very exciting, particularly because it matches the common real-world scenario where patients seek out a variety of different practitioners for help in managing difficult symptoms like fatigue,” says Kratz, assistant professor of physical medicine and rehabilitation.